Innate Immunity and Bacterial Quorum Sensing
先天免疫和细菌群体感应
基本信息
- 批准号:7149136
- 负责人:
- 金额:$ 35.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:BacteriaBacterial InfectionsBehaviorBloodC-terminalCell CommunicationCell DensityCellsCommunicationCommunication MethodsDataDrug DesignEnzymesEpithelial CellsFamilyGene ExpressionGeneticHost DefenseHost Defense MechanismHumanIn VitroInfectionInvestigationLactonesMass Spectrum AnalysisMediatingMediator of activation proteinMethionineModificationNatural ImmunityNitrogenNumbersObject AttachmentOxidasesOxygenPeptidesPeroxidasePeroxidasesPhagocytesPheromonePopulationPopulation DensitySignal TransductionStaphylococcus aureusSystemTestingVirulenceVirulence Factorsaryldialkylphosphatasedensityin vivomemberoxidationpathogenprogramsquorum sensing
项目摘要
DESCRIPTION (provided by applicant): Quorum sensing is a cell-to-cell communication system that permits members of a bacterial population to coordinate their behavior dependent on cell density. The mediators of quorum sensing are small, diffusible pheromones or autoinducers that signal gene expression programs at a sufficient bacterial density. The list of bacterial pathogens that use this method of communication to regulate host colonization and virulence is expanding and includes some of the most common pathogens of humans. We hypothesized that several mammalian effectors contribute to innate immunity by inhibiting pathogenic bacterial communication via "quorum quenching." In preliminary data we show that phagocyte-derived reactive oxygen and nitrogen intermediates (ROI and RNI) target a virulence-inducing peptide of the medically important human pathogen Staphylococcus aureus as an innate defense mechanism of the host. In addition, enzymes in blood and epithelial cells that cleave lactone bonds that are present in these autoinducers could inhibit quorum sensing-dependent virulence. To test this hypothesis, we will pursue the following specific aims: 1) To determine the contribution of phagocyte-derived ROI and RNI to host defense against infection with quorum sensing-sufficient and -deficient strains of S. aureus and S. epidermidis and the ability of ROI and RNI to functionally inactivate the virulence pheromones secreted by these pathogens; 2) To determine the ROI- and RNI-mediated modifications of these virulence pheromones by mass spectrometry in vitro and their biologic significance in vivo; and 3) To determine if non-phagocyte innate effectors inhibit quorum sensing-dependent virulence. These will include the paraoxonase enzyme family (thiolactonases) and the epithelial cell-expressed Nox/Duox enzymes (oxidases and peroxidases). Understanding the contribution of these innate effectors to quorum quenching and how pathogens avoid it could augment drug design that targets virulence pheromones for inactivation.
描述(由申请人提供):群体感应是一种细胞间通讯系统,允许细菌群体的成员根据细胞密度协调其行为。群体感应的介质是小的、可扩散的信息素或自诱导物,其在足够的细菌密度下发出基因表达程序的信号。使用这种通信方法来调节宿主定植和毒力的细菌病原体的列表正在扩大,包括一些最常见的人类病原体。我们假设,几种哺乳动物效应子通过“群体淬灭”抑制致病细菌的通讯,从而促进先天免疫。“在初步数据中,我们表明吞噬细胞衍生的活性氧和氮中间体(ROI和RNI)靶向医学上重要的人类病原体金黄色葡萄球菌的毒力诱导肽,作为宿主的先天防御机制。此外,血液和上皮细胞中的酶,裂解这些自身诱导物中存在的内酯键,可以抑制群体感应依赖性毒力。为了验证这一假设,我们将追求以下具体目标:1)确定吞噬细胞衍生的ROI和RNI对宿主防御群体感应充足和缺乏的S菌株感染的贡献。金黄色葡萄球菌和表皮细胞和ROI和RNI功能性地抑制这些病原体分泌的毒力信息素的能力; 2)通过体外质谱测定这些毒力信息素的ROI和RNI介导的修饰及其在体内的生物学意义;和3)确定非吞噬细胞先天效应物是否抑制群体感应依赖性毒力。这些将包括对氧磷酶家族(硫内酯酶)和上皮细胞表达的Nox/Duox酶(氧化酶和过氧化物酶)。了解这些先天效应子对群体淬灭的贡献以及病原体如何避免它可以增强靶向毒力信息素灭活的药物设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hattie D. Gresham其他文献
Hattie D. Gresham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hattie D. Gresham', 18)}}的其他基金
VLP-based Vaccines for Targeting Bacterial Virulence
基于 VLP 的针对细菌毒力的疫苗
- 批准号:
8024489 - 财政年份:2010
- 资助金额:
$ 35.56万 - 项目类别:
VLP-based Vaccines for Targeting Bacterial Virulence
基于 VLP 的针对细菌毒力的疫苗
- 批准号:
7877135 - 财政年份:2010
- 资助金额:
$ 35.56万 - 项目类别:
相似海外基金
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别:
Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 35.56万 - 项目类别: